The Food & Drug Administration's public health alert on Plavix is, as we point out in "The Pink Sheet" DAILY , a nice boos...

By now you've noticed that we are fascinated by the potential for a pharmacogenomic marker--variability in the CYP2C19 genotype--to play...

So will personalized medicine be the death of primary care? Maybe not. Maybe just the opposite. In this edition of the IN VIVO Blog Podcast ...